No­var­tis de­vel­op­ment chief John Tsai: 'We go deep in the new plat­form­s'

Dur­ing our re­cent Eu­ro­pean Bio­phar­ma Sum­mit, I talked with No­var­tis de­vel­op­ment chief John Tsai about his ex­pe­ri­ences over the 3-plus years he’s been at the phar­ma gi­ant. You can read the tran­script be­low or lis­ten to the ex­change in the link above.

John Car­roll: I fol­lowed your ca­reer for quite some time. You’ve had more than 20 years in big phar­ma R&D and you’ve ob­vi­ous­ly seen quite a lot. I re­al­ly was cu­ri­ous about what it was like for you three and a half years ago when you took over as R&D chief at No­var­tis. Ob­vi­ous­ly a big move, a lot of changes. You went to work for the for­mer R&D chief of No­var­tis, Vas Narasimhan, who had his own track record there. So what was the biggest ad­just­ment when you went in­to this po­si­tion?

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

San Diego, CA, USA